Phosphoproteomics delineates hepatocellular carcinoma subtypes and pinpoints therapeutic targets.
Zhang Z, Zhang Z, Zhang Y, Li Y, Li K, Liu S, Cao J, Li Y, Peng X, Li S, Yin Y, Jiang S, Zuo T, Chang L, Xu Z, Li C, Ding J, Wu J, Zhang W, Wang X, Xia G, Lu S, Xu P.
Zhang Z, et al. Among authors: lu s.
Hepatology. 2025 Jan 31. doi: 10.1097/HEP.0000000000001250. Online ahead of print.
Hepatology. 2025.
PMID: 39887258